Latest Insider Transactions at Haemonetics Corp (HAE)
This section provides a real-time view of insider transactions for Haemonetics Corp (HAE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HAEMONETICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HAEMONETICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2023
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-1.31%
|
$16,684
$86.57 P/Share
|
|
May 30
2023
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,304
-12.06%
|
$191,232
$83.33 P/Share
|
|
May 18
2023
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
1,423
-7.16%
|
$118,109
$83.34 P/Share
|
|
May 18
2023
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,385
-6.76%
|
$114,955
$83.34 P/Share
|
|
May 18
2023
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,541
-9.83%
|
$293,903
$83.34 P/Share
|
|
May 18
2023
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,087
-5.96%
|
$90,221
$83.34 P/Share
|
|
May 18
2023
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,839
-1.74%
|
$318,637
$83.34 P/Share
|
|
May 18
2023
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.61%
|
$7,470
$83.34 P/Share
|
|
May 16
2023
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-1.35%
|
$22,250
$89.21 P/Share
|
|
May 16
2023
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-1.58%
|
$28,391
$89.21 P/Share
|
|
May 16
2023
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
318
-1.53%
|
$28,302
$89.21 P/Share
|
|
May 16
2023
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
235
-1.56%
|
$20,915
$89.21 P/Share
|
|
May 16
2023
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,586
-0.71%
|
$141,154
$89.21 P/Share
|
|
May 16
2023
|
James D Arecca EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-2.42%
|
$31,061
$89.21 P/Share
|
|
May 16
2023
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-1.22%
|
$39,694
$89.21 P/Share
|
|
May 15
2023
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+13.17%
|
-
|
|
May 15
2023
|
Farris Maryanne Maunsell VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
630
+50.0%
|
-
|
|
May 15
2023
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
3,084
+13.24%
|
-
|
|
May 15
2023
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,364
+13.92%
|
-
|
|
May 15
2023
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
2,102
+12.23%
|
-
|
|
May 15
2023
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,225
+7.56%
|
-
|
|
May 15
2023
|
James D Arecca EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,205
+22.54%
|
-
|
|
May 15
2023
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,205
+10.34%
|
-
|
|
May 15
2023
|
Roy Galvin President, Global Plasma & BC |
BUY
Grant, award, or other acquisition
|
Direct |
2,243
+32.36%
|
-
|
|
May 12
2023
|
Simon, Christopher President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
854
-0.42%
|
$75,152
$88.16 P/Share
|
|
May 12
2023
|
Josep Llorens EVP, Global Manufacturing |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-0.66%
|
$9,944
$88.16 P/Share
|
|
May 12
2023
|
Michelle L Basil EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-0.63%
|
$17,952
$88.16 P/Share
|
|
May 12
2023
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.25%
|
$2,816
$88.16 P/Share
|
|
May 02
2023
|
James D Arecca EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
430
-4.03%
|
$34,830
$81.66 P/Share
|
|
Apr 14
2023
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
176
-1.02%
|
$14,784
$84.78 P/Share
|
|
Jan 23
2023
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
2,391
-12.18%
|
$215,190
$90.0 P/Share
|
|
Jan 23
2023
|
Josep Llorens EVP, Global Manufacturing |
BUY
Exercise of conversion of derivative security
|
Direct |
2,391
+10.86%
|
$133,896
$56.57 P/Share
|
|
Nov 11
2022
|
Simon, Christopher President & CEO |
SELL
Bona fide gift
|
Direct |
8,600
-4.02%
|
-
|
|
Nov 01
2022
|
Roy Galvin President, Global Plasma & BC |
BUY
Grant, award, or other acquisition
|
Direct |
2,382
+50.0%
|
-
|
|
Oct 24
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
180
-0.55%
|
$14,400
$80.39 P/Share
|
|
Oct 24
2022
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
75
-0.48%
|
$6,000
$80.39 P/Share
|
|
Sep 19
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
212
-1.64%
|
$16,112
$76.25 P/Share
|
|
Sep 19
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
11,448
-25.97%
|
$892,944
$78.36 P/Share
|
|
Sep 19
2022
|
Michelle L Basil EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,688
+6.45%
|
$390,960
$45.55 P/Share
|
|
Sep 15
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
33,798
-27.34%
|
$2,636,244
$78.13 P/Share
|
|
Sep 15
2022
|
Michelle L Basil EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
28,558
+13.28%
|
$1,285,110
$45.55 P/Share
|
|
Sep 06
2022
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
101
-0.58%
|
$7,373
$73.78 P/Share
|
|
Aug 15
2022
|
Mark W Kroll Director |
SELL
Open market or private sale
|
Direct |
8,016
-33.06%
|
$585,168
$73.71 P/Share
|
|
Aug 05
2022
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,730
+18.23%
|
-
|
|
Aug 05
2022
|
Claire Pomeroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,730
+21.88%
|
-
|
|
Aug 05
2022
|
Mark W Kroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,730
+10.12%
|
-
|
|
Aug 05
2022
|
Lloyd Emerson Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,730
+31.98%
|
-
|
|
Aug 05
2022
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,730
+8.85%
|
-
|
|
Aug 05
2022
|
Michael J Coyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,730
+24.82%
|
-
|
|
Aug 05
2022
|
Catherine M Burzik Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,730
+12.26%
|
-
|